Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Centre Hospitalier Universitaire Vaudois | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to implement a support interdisciplinary program(oncologists, pharmacists, physicians, nurses, leagues against cancer) of medication adherence to oral oncology treatments. The aim is to ensure continuity of care between professionals,effectiveness of treatment and patient safety.
80 patients will be included in swiss-romande hospitals and private oncologists and followed by thirty study pharmacies. Each refusal and drop-out will be documented. Follow-up duration is 48 weeks, with a motivational interviewing at least every three months. Patient adherence will be assessed electronically by MEMS (Medication Event Monitoring System).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Study population | Adults (18 years old or more) with one of the following oral oncology treatments: letrozole, exémestane, imatinib, sunitinib, nilotinib, evérolimus, déférasirox |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Change in Medication adherence | MEMS data, completed by informations given in motivational interviewing | 3 months, 6 months, 9 months, 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Program implementation | Evaluating the implementation of the program in pharmacies | 1 year |
| Oncologists, nurses, pharmacists and patients satisfaction | By questionnaire and interviews |
Not provided
Inclusion Criteria:
Exclusion Criteria:
- None
Not provided
Not provided
Not provided
Patient with cancer treated by oral medication in swiss-romande hospitals and private oncologists, and enrolled in the adherence program in one of the thirty studies pharmacies.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bugnon Olivier, Professor | Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland | Study Chair |
| Lüthi François, Dr | Clinique Bois-Cerf, Lausanne | Study Chair |
| Schneider Marie-Paule, PhD | Policlinique Medicale Universitaire | Principal Investigator |
| Chevaux Bernard, Dr | Centre Hospitalier Universitaire Vaudois | Principal Investigator |
| Troxler Stéphanie, PhD Student | Policlinique Medicale Universitaire | Principal Investigator |
| Leila Achtari, MD | Centre Hospitalier Univeristaire Vaudois | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Policlinique Médicale Universitaire and Centre pluridisciplinaire d'oncologie, CHUV | Lausanne | Canton of Vaud | 1010 | Switzerland |
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
| D055118 | Medication Adherence |
| D010349 | Patient Compliance |
| D010342 | Patient Acceptance of Health Care |
| ID | Term |
|---|---|
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
| D001519 | Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
| 1 year |
| Effect of Adverse Drug Reaction (ADR) on medication adherence | By MEMS data and motivational interviewing informations | 1 year |
| Change in Adverse Drug Reaction (ADR) | To evaluate the frequency and severity of ADR and the pharmacist's contribution to their management. Data from motivational interviewing. | 3 months, 6 months, 9 months, 12 months |